Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,788 | 26,634 | 13,269 | 23,774 | 21,100 |
| Receivables | 23,221 | 12,884 | 8,814 | 1,545 | N/A |
| Inventories | 1,565 | 1,060 | 2,156 | 576 | N/A |
| Other current assets | 1,731 | 466 | 44 | 63 | 253 |
| TOTAL | $67,043 | $44,124 | $26,858 | $26,728 | $22,387 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,508 | 822 | 6 | 211 | 27 |
| TOTAL | $3,508 | $822 | $6 | $211 | $27 |
| Total Assets | $70,551 | $44,946 | $26,864 | $26,939 | $22,414 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,635 | 3,241 | 3,778 | 2,390 | 777 |
| Accrued Expenses | 5,635 | 3,428 | 3,754 | 2,219 | 877 |
| Other current liabilities | 248 | 248 | N/A | N/A | N/A |
| TOTAL | $10,518 | $6,919 | $7,553 | $4,609 | $1,654 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 18,067 | 29,712 | 24,639 | 4,988 |
| Other Non-Current Liabilities | 24,561 | 25,832 | 1,221 | 260 | 0 |
| TOTAL | $24,561 | $43,899 | $30,933 | $24,899 | $4,988 |
| Total Liabilities | $35,079 | $50,818 | $38,486 | $29,508 | $6,642 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,475 | 27,594 | 27,100 | 26,412 | 26,014 |
| Common Shares | 189,906 | 145,608 | 144,307 | 142,591 | 140,801 |
| Retained earnings | -229,422 | -219,681 | -219,245 | -203,200 | -179,486 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $35,472 | $-5,872 | $-11,622 | $-2,569 | $15,772 |
| Total Liabilities And Equity | $70,551 | $44,946 | $26,864 | $26,939 | $22,414 |